(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 597.14%6.78M | ---- | -100.69%-1.36M | ---- | 269.84%197.24M | ---- | 34.12%-116.13M | ---- | -273.86%-176.29M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 38.98%-3.72M | ---- | -29.26%-6.1M | ---- | -162.44%-4.72M | ---- | -32.42%-1.8M | ---- | 70.67%-1.36M |
Attributable subsidiary (profit) loss | ---- | -1,058.10%-42.42M | ---- | 103.41%4.43M | ---- | -236.42%-129.71M | ---- | -96.41%-38.56M | ---- | 15.09%-19.63M |
Impairment and provisions: | ---- | 315.27%97.99M | ---- | -282.73%-45.52M | ---- | -107.22%-11.89M | ---- | 2.78%164.63M | ---- | 273.92%160.18M |
-Impairment of property, plant and equipment (reversal) | ---- | 315.83%98.11M | ---- | -278.80%-45.46M | ---- | ---12M | ---- | ---- | ---- | 301.25%165.72M |
-Impairment of trade receivables (reversal) | ---- | -95.16%-121K | ---- | -157.94%-62K | ---- | --107K | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3,072.75%164.63M | ---- | 43.23%-5.54M |
Revaluation surplus: | ---- | 18.63%54.75M | ---- | 283.31%46.15M | ---- | -73.79%12.04M | ---- | -26.61%45.93M | ---- | 60.74%62.58M |
-Fair value of investment properties (increase) | ---- | 10.73%54.75M | ---- | 310.67%49.45M | ---- | -73.79%12.04M | ---- | -26.61%45.93M | ---- | 60.74%62.58M |
-Other fair value changes | ---- | ---- | ---- | ---3.29M | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---28.82M | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---28.82M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -1.83%5M | ---- | 52.42%5.09M | ---- | -3.35%3.34M | ---- | 15.73%3.46M | ---- | 93.15%2.99M |
-Amortization of intangible assets | ---- | --390K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Financial expense | ---- | -35.52%22.33M | ---- | -18.09%34.63M | ---- | -21.10%42.27M | ---- | 61.73%53.58M | ---- | 389.03%33.13M |
Special items | ---- | -450.00%-33K | ---- | 99.93%-6K | ---- | -3,725.21%-8.95M | ---- | -10.38%-234K | ---- | 98.28%-212K |
Operating profit before the change of operating capital | ---- | 277.00%140.67M | ---- | -47.30%37.31M | ---- | -36.14%70.8M | ---- | 80.61%110.88M | ---- | 273.04%61.39M |
Change of operating capital | ||||||||||
Developing property (increase)decrease | ---- | 453.03%593.41M | ---- | 39.53%-168.09M | ---- | 41.85%-277.99M | ---- | 21.99%-478.03M | ---- | -44.20%-612.79M |
Accounts receivable (increase)decrease | ---- | -17.39%1.76M | ---- | 6.27%2.13M | ---- | 215.07%2.01M | ---- | -284.66%-1.75M | ---- | 155.01%945K |
Accounts payable increase (decrease) | ---- | -285.50%-138.32M | ---- | 2,885.51%74.57M | ---- | -101.31%-2.68M | ---- | 22.33%204.83M | ---- | -0.65%167.44M |
prepayments (increase)decrease | ---- | -8.57%59.66M | ---- | 341.16%65.25M | ---- | 68.62%-27.06M | ---- | -46.42%-86.21M | ---- | -130.77%-58.88M |
Special items for working capital changes | ---- | -722.22%-395.91M | ---- | -116.16%-48.15M | ---- | 3.35%298.04M | ---- | 1,814.28%288.38M | ---- | -230.06%-16.82M |
Cash from business operations | ---- | 806.63%261.28M | ---- | -158.57%-36.98M | ---- | 65.71%63.13M | ---- | 108.30%38.1M | ---- | -1,126.99%-458.72M |
Other taxs | ---- | 44.99%-16.39M | ---- | 24.78%-29.79M | ---- | -250.53%-39.6M | ---- | 27.99%-11.3M | ---- | 69.56%-15.69M |
Special items of business | -95.01%10.94M | ---- | 330.44%219.43M | ---- | -1,321.68%-95.22M | ---- | -58.50%-6.7M | ---- | 98.96%-4.23M | ---- |
Net cash from operations | -95.01%10.94M | 466.80%244.89M | 330.44%219.43M | -383.79%-66.76M | -1,321.68%-95.22M | -12.21%23.53M | -58.50%-6.7M | 105.65%26.8M | 98.96%-4.23M | -433.53%-474.41M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -15.32%1.03M | -40.52%3.62M | -59.69%1.21M | 62.41%6.08M | 61.41%3.01M | 252.12%3.74M | 448.82%1.87M | 53.61%1.06M | 41.67%340K | -49.27%692K |
Dividend received - investment | --48.5M | ---- | ---- | --60M | --60M | ---- | ---- | ---- | ---- | --210M |
Loan receivable (increase) decrease | ---- | ---- | 7.69%-24M | ---- | ---26M | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | ---- | -123.81%-4.15M | -1,800.00%-1.5M | -209.18%-1.85M | ---79K | 80.58%-599K | ---- | -65.98%-3.08M | -458.89%-3.02M | -20.57%-1.86M |
Purchase of intangible assets | ---- | ---3.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --340.58M | --242M | ---- | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | --14.6M | --12.39M | ---- | ---- | --3M | --3M | ---- |
Cash on investment | ---- | -343.09%-2.15M | -1,147.22%-6.05M | 91.83%-485K | -1,112.50%-485K | -89.86%-5.94M | 98.59%-40K | -12.81%-3.13M | -127.72%-2.84M | 43.83%-2.77M |
Other items in the investment business | ---- | --140.87M | ---- | ---- | ---- | ---3K | ---- | ---- | ---- | ---- |
Net cash from investment operations | 263.26%49.53M | 71.41%134.29M | -162.12%-30.34M | -76.81%78.34M | -79.97%48.83M | 15,832.93%337.79M | 9,775.48%243.82M | -101.04%-2.15M | -102.85%-2.52M | 4,132.54%206.06M |
Net cash before financing | -68.02%60.47M | 3,175.00%379.18M | 507.62%189.1M | -96.80%11.58M | -119.56%-46.39M | 1,365.71%361.31M | 3,615.03%237.12M | 109.19%24.65M | 97.88%-6.75M | -185.39%-268.35M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | 736.25%133.8M | --129.8M | -97.42%16M | ---- | -21.39%620.58M | 69.85%612.32M | 146.71%789.47M |
Refund | 71.65%-52.95M | -22.13%-315.2M | -18.98%-186.8M | -30.46%-258.08M | -106.53%-157M | 70.45%-197.82M | 85.20%-76.02M | -106.67%-669.39M | -527.53%-513.66M | -54.24%-323.9M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 600.00%35M |
Other items of the financing business | -116.57%-4.6M | 36.38%-19.87M | 86.77%-2.12M | 52.22%-31.23M | 64.01%-16.05M | -11.21%-65.37M | -48.99%-44.59M | 26.08%-58.78M | -210.49%-29.93M | -175.22%-79.52M |
Net cash from financing operations | 69.12%-58.6M | -114.49%-336.8M | -331.21%-189.77M | 36.95%-157.02M | 63.78%-44.01M | -128.12%-249.02M | -278.77%-121.51M | -126.01%-109.16M | -77.22%67.97M | 387.40%419.68M |
Effect of rate | 1,972.73%228K | -60.38%21K | 155.00%11K | 243.24%53K | -81.82%-20K | 37.29%-37K | -157.89%-11K | -356.52%-59K | 216.67%19K | -34.29%23K |
Net Cash | 379.40%1.87M | 129.14%42.38M | 99.26%-670K | -229.53%-145.44M | -178.19%-90.4M | 232.87%112.29M | 88.86%115.62M | -155.84%-84.51M | 411.57%61.22M | 2,010.31%151.34M |
Begining period cash | 55.17%119.26M | -65.42%76.86M | -65.42%76.86M | 102.05%222.25M | 102.06%222.25M | -43.47%110M | -43.47%109.99M | 350.28%194.57M | 350.28%194.57M | -15.44%43.21M |
Cash at the end | 59.26%121.36M | 55.17%119.26M | -42.20%76.2M | -65.42%76.86M | -41.56%131.83M | 102.05%222.25M | -11.81%225.6M | -43.47%110M | 985.41%255.81M | 350.28%194.57M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Zheng Zheng Certified Public Accountants Co., Ltd. | -- | Zheng Zheng Certified Public Accountants Co., Ltd. | -- | Zheng Zheng Certified Public Accountants Co., Ltd. | -- | Zheng Zheng Certified Public Accountants Co., Ltd. | -- | Zheng Zheng Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data